The global pharmaceutical packaging market size is expected to reach USD 265.70 billion by 2030, registering a CAGR of 9.7% from 2024 to 2030, according to a new report by Grand View Research, Inc., The increasing prevalence of chronic diseases coupled with the growth of the pharmaceutical industry is anticipated to augment the consumption of pharmaceutical packaging products.
Ban on counterfeit products in North America and Europe is expected to be a major driver for the market as major companies are likely to invest heavily in anti-counterfeit packaging products. Blow-Fill-Seal (BFS) technology allows customized design for high-quality containers with tamper-evident closures in multiple shapes and sizes. Therefore, the growing demand for anti-counterfeiting packaging along with the advent of technology is likely to support the growth of tamper-evident pharmaceutical packaging.
Companies are focusing on using sustainable materials for packaging owing to the rising concerns about the generation of packaging waste that is difficult to degrade. Bioplastic is likely to gain traction in the market as it is derived from renewable plant-based sources and is biodegradable unlike plastics and polymers derived from fossil fuels. In May 2022, SGD Pharma has launched the industry’s first Ready-to-Use sterile 100 ml molded glass vials. It is manufactured with SG EZ-fill packaging technology. Such novel sustainable packaging solutions are expected to boost the growth of the market.
Pharmaceutical manufacturers are likely to prefer blister packaging for tablets and capsules as these are more sustainable with minimal usage of packaging material as compared to rigid bottles. In addition, the transparency of blister packs provides a clear product display and provides tamper-resistant features. The outbreak of COVID-19 has significantly increased the demand for various pharmaceutical drugs across the world, thereby propelling the demand for pharmaceutical manufacturing and packaging. Rapid development and production of the vaccine in the year 2020 are anticipated to increase pharmaceutical manufacturing considerably, primarily benefitting the manufacturers of packaging vials in the near future.
Market players have been trying to increase their production capabilities as well as expand their geographic reach. In addition, companies are introducing and investing in high-tech packaging solutions in the changing environment. For instance, In April 2021, Amcor plc announced the development of recyclable Polyethylene-based thermoform blister packaging under the brand name AmSky. The development is aimed at sustainable packaging that can reduce carbon footprint. The product is expected to reduce carbon footprint up to 70%. Companies are expected to invest significantly in such developments in the coming years to strengthen their market position.
Request a free sample copy or view report summary: Pharmaceutical Packaging Market Report
Asia Pacific is expected to register the fastest CAGR of more than 12% from 2024 to 2030. This growth is due to the rapidly expanding pharmaceutical market, particularly in China & India, and rising cases of various diseases, such as cancer and heart problems
In terms of material, the glass segment is projected to ascend at the highest CAGR of 10.3% over the forecast period. Strong chemical resistance to various medicinal products and the ability to withstand heating treatment during the sterilization process is expected to expand the penetration of glass packaging
Pharma manufacturing is the key end-use segment that accounted for the highest share of 49.9% in 2023 and is expected to witness strong growth from 2024 to 2030. This is owing to the increasing demand for medicines.
In April 2022, Amcor has launched new and more sustainable High Shield laminates to its pharmaceutical packaging portfolio. This is low carbon, recycle-ready, and moisture resistant packaging solution, thus end use companies’ recyclability agendas
Grand View Research has segmented the pharmaceutical packaging market on the basis of on material, product, drug delivery mode, end-use, and region:
Pharmaceutical Packaging Material Outlook (Volume, Kilotons; Revenue, USD Million, 2018 - 2030)
Plastics & Polymers
Polyvinyl Chloride (PVC)
Polypropylene (PP)
Homo
Random
Polyethylene Terephthalate (PET)
Polyethylene (PE)
HDPE
LDPE
LLDPE
Polystyrene (PS)
Others
Paper & Paperboard
Glass
Aluminium Foil
Others
Pharmaceutical Packaging Product Outlook (Revenue, USD Million, 2018 - 2030)
Primary
Plastic Bottles
Caps & Closures
Parenteral Containers
Blister Packs
Prefillable Inhalers
Pouches
Medication Tubes
Others
Secondary
Prescription Containers
Pharmaceutical Packaging Accessories
Tertiary
Pharmaceutical Packaging Drug Delivery Mode Outlook (Revenue, USD Million, 2018 - 2030)
Oral Drugs
Injectables
Topical
Ocular/ Ophthalmic
Nasal
Pulmonary
Transdermal
IV Drugs
Others
Pharmaceutical Packaging End-use Outlook (Revenue, USD Million, 2018 - 2030)
Pharma Manufacturing
Contract Packaging
Retail Pharmacy
Institutional Pharmacy
Pharmaceutical Packaging Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
Russia
Turkey
Asia Pacific
China
India
Japan
South Korea
Australia
Southeast Asia
Central & South America
Brazil
Argentina
Middle East & Africa
Saudi Arabia
UAE
South Africa
Egypt
List of Key Players in the Pharmaceutical Packaging Market
Amcor plc
Becton, Dickinson, and Company
AptarGroup, Inc.
Drug Plastics Group
Gerresheimer AG
Schott AG
Owens Illinois, Inc.
West Pharmaceutical Services, Inc.
Berry Global, Inc.
WestRock Company
SGD Pharma
International Paper
Comar, LLC
CCL Industries, Inc.
Vetter Pharma International
"The quality of research they have done for us has been excellent..."